Literature DB >> 12875773

Fibrosis of the left atria during progression of heart failure is associated with increased matrix metalloproteinases in the rat.

Christophe Boixel1, Vincent Fontaine, Catherine Rücker-Martin, Paul Milliez, Liliane Louedec, Jean Baptiste Michel, Marie Paule Jacob, Stéphane N Hatem.   

Abstract

OBJECTIVES: The purpose of this study was to determine the pathogenic factors and molecular mechanisms involved in fibrosis of the atria.
BACKGROUND: Fibrosis is an important component of the pathophysiology of atrial fibrillation, especially when the arrhythmia is associated with heart failure (HF) or atrial dilation.
METHODS: We used a rat model of myocardial infarction (MI) complicated by various degrees of left ventricular dysfunction and atrial dilation to study fibrosis and matrix metalloproteinase (MMP) activity in the left atrial (LA) myocardium by means of histologic, Western blot, zymographic, and immunohistologic techniques.
RESULTS: Three months after surgical ligature of the left coronary artery, 27 rats had a large MI, 12 were in mild HF, and 15 in severe HF. Both groups had LA enlargement at the echocardiography. Masson's trichrome and picrosirius staining of tissue sections revealed marked fibrosis at the periphery of trabeculae and also surrounding myolytic myocytes, in both mild and severe HF. In mild HF, the activity and expression of the matrilysin MMP-7 were increased (122%), whereas in severe HF, both MMP-7 (211%) and the gelatinase MMP-2 (187%) were up-regulated. There were no changes in the expression or activity of MMP inhibitors, TIMP-1, -2, and -4. Immunostaining of cryosections showed that MMP-2 was present in the interstitial spaces, whereas MMP-7 accumulated in myolytic myocytes.
CONCLUSIONS: Hemodynamic overload of the atria is an important pathogenic factor of fibrosis; MMP-7 appears to be involved in the early stage of this tissue remodeling process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12875773     DOI: 10.1016/s0735-1097(03)00578-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  50 in total

Review 1.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

Review 2.  Effects of Bariatric Surgery on Heart Rhythm Disorders: a Systematic Review and Meta-Analysis.

Authors:  Elijah E Sanches; Besir Topal; Frank W de Jongh; Eylem Cagiltay; Alper Celik; Magnus Sundbom; Rui Ribeiro; Chetan Parmar; Surendra Ugale; Kamal Mahawar; Marc P Buise; Lukas R Dekker; Dharmanand Ramnarain; Sjaak Pouwels
Journal:  Obes Surg       Date:  2021-03-13       Impact factor: 4.129

Review 3.  Role of various proteases in cardiac remodeling and progression of heart failure.

Authors:  Alison L Müller; Naranjan S Dhalla
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

Review 4.  Immunopathogenesis and biomarkers of recurrent atrial fibrillation following ablation therapy in patients with preexisting atrial fibrillation.

Authors:  John H Rosenberg; John H Werner; Gilman D Plitt; Victoria V Noble; Jordan T Spring; Brooke A Stephens; Aleem Siddique; Helenmari L Merritt-Genore; Michael J Moulton; Devendra K Agrawal
Journal:  Expert Rev Cardiovasc Ther       Date:  2018-12-29

5.  Age-related atrial fibrosis.

Authors:  Felix Gramley; Johann Lorenzen; Christian Knackstedt; Obaida R Rana; Erol Saygili; Dirk Frechen; Sven Stanzel; Francesco Pezzella; Eva Koellensperger; Christian Weiss; Thomas Münzel; Patrick Schauerte
Journal:  Age (Dordr)       Date:  2008-10-07

Review 6.  Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?

Authors:  Annamaria Mascolo; Konrad Urbanek; Antonella De Angelis; Maurizio Sessa; Cristina Scavone; Liberato Berrino; Giuseppe Massimo Claudio Rosano; Annalisa Capuano; Francesco Rossi
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

7.  Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.

Authors:  Jalahalli M Siddesha; Anthony J Valente; Siva S V P Sakamuri; Tadashi Yoshida; Jason D Gardner; Naveen Somanna; Chiaki Takahashi; Makoto Noda; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2013-10-02       Impact factor: 5.000

8.  Effects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing.

Authors:  J Zhao; J Li; W Li; Y Li; H Shan; Y Gong; B Yang
Journal:  Br J Pharmacol       Date:  2010-01-15       Impact factor: 8.739

9.  Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI.

Authors:  Christopher McGann; Nazem Akoum; Amit Patel; Eugene Kholmovski; Patricia Revelo; Kavitha Damal; Brent Wilson; Josh Cates; Alexis Harrison; Ravi Ranjan; Nathan S Burgon; Tom Greene; Dan Kim; Edward V R Dibella; Dennis Parker; Rob S Macleod; Nassir F Marrouche
Journal:  Circ Arrhythm Electrophysiol       Date:  2013-12-20

10.  Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.

Authors:  Ravi K Mareedu; Ihab B Abdalrahman; Kodlipet C Dharmashankar; Juan F Granada; Po-Huang Chyou; Param P Sharma; Peter N Smith; John J Hayes; Robert T Greenlee; Humberto Vidaillet
Journal:  Clin Med Res       Date:  2009-11-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.